[1]
N. V. V. Hau, “A single - center, retrospective observational study comparing the efficacy of empagliflozin and dapagliflozin as add-on therapy in type 2 diabetic patients”, JCMHCH, vol. 16, no. 8, pp. 81–88, Nov. 2024.